ProMIS Neurosciences Announces First Quarter 2020 Results

    NEXT STORY
    Capricor Announces Positive Top-Line Final Results from HOPE-2 Study in Patients with Duchenne Muscular Dystrophy Treated with Lead Candidate CAP-1002
    PREV STORY
    PDS Biotechnology Reports Financial Results for the First Quarter 2020 and Provides Business Update
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Novavax Reports Second Quarter 2019 Financial Results

    author_avatar
    NASDAQ Market News

    I-Mab Announces Upcoming Participation at May Conferences

    author_avatar
    NASDAQ Market News

    Crown Bioscience Expands Cardiovascular & Metabolic Disease Research Capability

    The Company Offers New Non-GLP Services & Translational Rodent Models at its expanded site ...

    author_avatar
    NASDAQ Market News